Pharmaceutical News

RSS

New study raises safety concerns on clinical use of caspase inhibitors for liver diseases

Many acute and chronic liver diseases, including alcoholic hepatitis, result from apoptotic (programmed) cell death mediated by the enzyme caspase. Caspase inhibitors have therapeutic potential to treat and prevent apoptosis-mediated liver injury, and some are currently in clinical trials.

9 Sep 2016

CHORI scientists reveal improved protective antibody responses to new meningococcal vaccine

A study conducted by UCSF Benioff Children's Hospital Oakland Research Institute scientists shows greatly improved protective antibody responses to a new mutant vaccine antigen for prevention of disease caused by Neisseria meningitidis - also known as meningococcus - that has the potential to improve the current vaccines for meningitis.

9 Sep 2016

New research could pave way for safe, effective treatment for muscular dystrophy

New research has shown that the corticosteroid deflazacort is a safe and effective treatment for Duchenne muscular dystrophy. The findings, which appear this month in the journal Neurology, could pave the way for first U.S.-approved treatment for the disease.

9 Sep 2016

Steroids for treating infertility in women may have harmful effects on pregnancy and child

Researchers at the University of Adelaide are urging doctors and patients to refrain from using a specific steroid treatment to treat infertility in women unless clinically indicated, because of its links to miscarriage, preterm birth and birth defects.

9 Sep 2016

New mouse model helps identify potential drug target for hard-to-treat social aspects of ASD

A study of a new mouse model identifies a drug target that has the potential to increase social interaction in individuals with some forms of autism spectrum disorder (ASD), according to researchers in the Perelman School of Medicine at the University of Pennsylvania. The team published their work in Biological Psychiatry.

9 Sep 2016

UC researchers offer more insights into how lack of gut bacteria influences fat absorption

A study led by University of Cincinnati lipid metabolism researchers lends additional insight into how bacteria in the gut, or lack thereof, influences intestinal mast cells (MMC) activation and perhaps fat absorption.

9 Sep 2016

Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

In research published online today in Science, a team of scientists describe a new therapeutic strategy to target a hidden Achilles' heel shared by all known types of Ebola virus.

8 Sep 2016

Research could pave way for more effective and safer anti-epilepsy drugs

Columbia University Medical Center researchers have discovered how a new epilepsy drug works, which may lead the way to even more effective and safer medications.

8 Sep 2016

Trial of high-dose flu vaccine aims to better protect heart failure patients

A network of researchers in the United States and Canada will try to spare thousands of patients the dangers of heart attacks and hospitalizations over the next five years in a trial of a high-dose flu vaccine.

8 Sep 2016

Researchers reveal potential therapeutic treatment for alphavirus infections

Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment for the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus (RRV) and Chikungunya Virus (CHIKV).

8 Sep 2016

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

8 Sep 2016

Component of general anesthetic shows improvement in patients with treatment-resistant depression

A new study in Biological Psychiatry reports that esketamine, a component of the general anesthetic ketamine, shows rapid and significant improvement in depressive symptoms in patients who do not respond to currently available therapies.

8 Sep 2016

Researchers reveal how traditional Chinese medicine helps treat various cancers

Researchers at the University of Adelaide have shown how a complex mix of plant compounds derived from ancient clinical practice in China - a Traditional Chinese Medicine - works to kill cancer cells.

8 Sep 2016

New vaccine against grass pollen allergies may help combat hepatitis B infection

A new type of vaccine against grass pollen allergies (BM32) might also offer an effective treatment for combating hepatitis B infection.

8 Sep 2016

BetterYou welcomes research linking low vitamin D levels to asthma attacks

A daily oral sunshine spray could be the answer to halving the risk of severe asthma attacks, after a recent study suggested that taking a vitamin D supplement can help by reducing inflammation in the lungs and warding off viruses.

From BetterYou Ltd 8 Sep 2016

New collaborative initiative seeks to develop interventions for optimizing adult vaccination rates

A new quality improvement initiative that aims to create effective solutions in optimizing adult vaccination rates was announced today.

8 Sep 2016

Study finds rising trends in marijuana use among college students

College student marijuana use continues its nearly decade-long increase, according to the most recent national Monitoring the Future study.

8 Sep 2016

Patients with noninfectious uveitis can get effective treatment from corticosteroid alternative

Patients suffering from noninfectious uveitis, a group of diseases that causes eye inflammation, can get effective treatment from a corticosteroid alternative that has previously been approved for treatment of arthritis and Crohn's disease, according to a study led by a Duke Health researcher.

8 Sep 2016

Experimental drug shows promise for stopping melanoma and other forms of cancer

An experimental cancer drug works differently than intended and shows significant promise for stopping melanoma and possibly other forms of cancer, research from the University of Virginia School of Medicine suggests.

7 Sep 2016

New molecular mechanism may explain pain relieving drug’s diverse benefits

Aspirin's ability to reduce the risk of both cardiovascular disease and colon cancer has been a welcome, yet puzzling, attribute of the pain reliever that has been a mainstay in medicine cabinets for more than 100 years.

7 Sep 2016

Pharmaceutical News

New study raises safety concerns on clinical use of caspase inhibitors for liver diseases

CHORI scientists reveal improved protective antibody responses to new meningococcal vaccine

New research could pave way for safe, effective treatment for muscular dystrophy

Steroids for treating infertility in women may have harmful effects on pregnancy and child

New mouse model helps identify potential drug target for hard-to-treat social aspects of ASD

UC researchers offer more insights into how lack of gut bacteria influences fat absorption

Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

Research could pave way for more effective and safer anti-epilepsy drugs

Trial of high-dose flu vaccine aims to better protect heart failure patients

Researchers reveal potential therapeutic treatment for alphavirus infections

New immunotherapy treatment may offer hope for many pancreatic cancer patients

Component of general anesthetic shows improvement in patients with treatment-resistant depression

Researchers reveal how traditional Chinese medicine helps treat various cancers

New vaccine against grass pollen allergies may help combat hepatitis B infection

BetterYou welcomes research linking low vitamin D levels to asthma attacks

New collaborative initiative seeks to develop interventions for optimizing adult vaccination rates

Study finds rising trends in marijuana use among college students

Patients with noninfectious uveitis can get effective treatment from corticosteroid alternative

Experimental drug shows promise for stopping melanoma and other forms of cancer

New molecular mechanism may explain pain relieving drug’s diverse benefits

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News